iPS Cell Patent Dispute between BioGatekeeper and Nobel LaureateYamanaka

There have been numerous IP claims and patents related to cellular reprogramming and iPS cells, but the dominant patent has been U.S. Patent No. 8,058,065 to Yamanaka et al. that was issued on November 15, 2011, which has been commonly known as the “Yamanaka Patent”. However, BioGater claims priority of similar techniques with its own pantent US 7682828